Treatment of lymphatic malformations with lyophilized powder of Streptococcus pyogenes cells (picibanil/OK-432). A practical overview;Behandlung lymphatischer malformationen mit lysat attenuierter streptokokken (picibanil/OK-432). Praktische anleitung

Monatsschrift fur Kinderheilkunde

Volumn 155, Issue 11, 2007, Pages 1077-1082

  Helmstaedter, V ^a   Quante, G ^a   Roth, B ^a   Huttenbrink, K B ^a   Wittekindt, C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Lymphatic malformation; Lyophilized powder of Streptococcus pyogenes cells; Picibanil (OK 432); Resection; Sclerotherapy

Indexed keywords

PICIBANIL;

ALTERNATIVE MEDICINE; ARTICLE; BACTERIAL CELL; COMPUTER ASSISTED TOMOGRAPHY; DRUG ADMINISTRATION ROUTE; ECHOGRAPHY; FREEZE DRYING; HEAD AND NECK MALFORMATION; HUMAN; IMMUNOMODULATION; INTRACYSTIC APPLICATION; LYMPHATIC MALFORMATION; LYOPHILIZED POWDER; MACROPHAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; SCLEROTHERAPY; STREPTOCOCCUS PYOGENES; SURGICAL APPROACH; TREATMENT INDICATION;

EID: 36349035227     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00112-007-1505-x     Document Type: Article

References (16)

1. Banieghbal B, Davies MR (2003) Guidelines for the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg 13: 103-107
2. Bloom DC, Perkins JA, Manning SC (2004) Management of lymphatic malformations. Curr Opin Otolaryngol Head Neck Surg 12: 500-504
3. Claesson G, Kuylenstierna R (2002) OK-432 therapy for lymphatic malformation in 32 patients (28 children). Int J Pediatr Otorhinolaryngol 65: 1-6
4. Giguere CM, Baumann NM, Sato Y et al. (2002) Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg 128: 1137-1144
5. Greinwald JH Jr, Burke DK, Sato Y et al. (1999) Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg 121: 381-387
6. Hall N, Ade-Ajayi N, Brewis C et al. (2003) Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? Surgery 133: 238-242
7. Kim KH, Sung MW, Roh JL et al. (2004) Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg 131: 307-316
8. Ogita S, Tsuto T, Nakamura K et al. (1994) OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29: 784-785
9. Ogita S, Tsuto T, Nakamura K et al. (1996) OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg 31: 477-480
10. Ogita S, Tsuto T, Tokiwa K et al. (1987) Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 74: 690-691
11. Orvidas LJ, Kasperbauer JL (2000) Pediatric lymphangiomas of the head and neck. Ann Otol Rhinol Laryngol 109: 411-421
12. Rautio R, Keski-Nisula L, Laranne J et al. (2003) Treatment of lymphangiomas with OK-432 (Picibanil). Cardiovasc Intervent Radiol 26: 31-36
13. Sichel JY, Udassin R, Gozal D et al. (2004) OK-432 therapy for cervical lymphangioma. Laryngoscope 114: 1805-1809
14. Smith RJ, Burke DK, Sato Y et al. (1996) OK-432 therapy for lymphangiomas. Arch Otolaryngol Head Neck Surg 122: 1195-1199
15. Werner JA, Duenne AA, Folz BJ et al. (2001) Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 258: 141-149
16. Wittekindt C, Michel O, Streppel M et al. (2006) Lymphatic malformations of the head and neck: Introduction of a disease score for children, Cologne Disease Score (CDS). Int J Pediatr Otorhinolaryngol 70: 1205-1212